Press Release

FOR IMMEDIATE RELEASE

QL2 Providing Competitive Intelligence Solutions to Five
of the Top 10 Pharmaceutical Companies

WebQL helps automate competitive data extraction process, delivering business critical information to help pharmaceutical companies be more agile

SEATTLE — May 8, 2007 — QL2 Software today announced that it now supports five of the top ten pharmaceutical companies with their on demand data extraction and integration solutions. These organizations use QL2's technology to monitor competitors, clinical trials status and adverse events. QL2 allows these organizations to improve business processes, extract information from the Web as well as unstructured and structured data that exists in internal silos in public websites. These pharmaceutical companies integrate this critical data into internal process, business intelligence solutions and applications for a 360-degree view of their business and the market.

"For pharmaceutical companies, it is no secret that constant surveillance of the competitive landscape, having access to critical business data and understanding changing regulatory and industry data is absolutely crucial to success," said Greg Lauckhart, QL2 Co-President and Chief Technology Officer. "With our solutions, pharmaceutical companies can find precise data allowing them to increase their knowledge of critical information. This data includes everything from clinical trials, competitive threats, public perception and alternative futures for their products. When they have the most recent and accurate information at their fingertips, they can analyze this important data to make intelligent strategic business decisions."

Within many pharmaceutical companies are competitive intelligence teams, which work cross-organizationally to develop a compelling and more competitive strategy to take products to market. QL2 supplements these teams' efforts by automating the business analytics and data extraction processes, which reduces the time it takes to collect data from multiple internal and external sources. As a result, these teams can spend more time analyzing information rather than manually searching, then cutting and pasting information into various databases.

"Public databases typically reside outside the reach of traditional search engines, and can be vital for pharmaceutical companies looking to invest in new market opportunities, plan partnerships or protect their company from potential legal concerns," added Lauckhart. "Traditionally this required a manual intelligence gathering process by the analysts which is tedious and very time consuming. QL2 can go deeper and more quickly into areas of the Web that traditional search engines can not, delivering more relevant information that allows organizations to be more agile and respond quicker to changing business needs and climates."

QL2 Solutions eliminate the drain on IT resources by allowing users to manage their data extraction activities from their desktop or browser. QL2 automatically extracts data directly from existing systems, interfaces and the Web, including unstructured information found in PDFs, PowerPoint presentations, Word docs and email archives, then seamlessly integrates it into the format or system being used by its customers.

About QL2 Software, Inc.
QL2 Software is the leading provider of on demand data extraction and integration solutions that empower BI, CI, enterprise search and text analytics applications to deliver the data that drives the enterprise for over 200 companies in 34 countries. In 2005, QL2 joined IBM's Unstructured Information Management Architecture (UIMA) open source initiative, was named to KMWorld's "Top 100 Companies" and "Trend-Setting Products of 2006" in addition to placing high on the list of Fastest Growing Private Companies in Washington by the Puget Sound Business Journal for two consecutive years. www.QL2.com

Download a PDF version of this press release.